Scientists find drugs for cancer, hepatitis C can kill Zika in petri dish. But will they work in humans?
Scientists have discovered three existing drugs — used for cancer, hepatitis C and for parasitic infections — that they say appear promising against the Zika virus. The experiments were conducted only in lab-grown human cells in petri dishes, but the results were dramatic. Zika is so devastating that the damage it does has been thought to be irreversible. But the researchers […]Related:Pocket Porn: Why Anthony Weiner can’t seem to stop sextingMore parents believe vaccines are ‘unnecessary,’ while a mumps outbreak growsSingapore Zika cases rise to 56 at one construction site; Malaysia starts border screening
Markus Schosserer, Johannes Grillari, Michael Breitenbach
Alan Dal Pra, Thomas Zilli, Stephane Supiot
This article is protected by copyright. All rights reserved.
Adebola Giwa, Rizwan Ahmed, Thomas Donner, Hideo Yagita, Abdel Rahim A. Hamad
ConclusionsSubcutaneous immunotherapy with depigmented‐polymerized allergen extracts is a safe and clinically effective treatment for LAR to Phleum pratense.clinicaltrials. gov identifier: NCT02126111.This article is protected by copyright. All rights reserved.
A new global malaria crisis could be triggered by a resistant-strain form of malaria discovere din Southeast Asia. Scientists are hopeful they can nip it in the bud but fear it may soon go further afield
This amount cuts the risk of heart disease by 15% and early death by 17%, found the University of Southampton. It also slashes chances of certain cancers, diabetes, liver disease and dementia.
Conclusions: miR-27a, miR-27b, miR-9, miR10a and miR-10b were up-regulated in PDAC cells compared to HPDE cells. The up-regulation of these miRNAs was not responsible for the down-regulation of RAR α, RARβ, RXRα and RXRβ in PDAC cells.Cell Physiol Biochem 2017;44:644 –656